Bone Age Assessment in a 14.5-Year-Old with 2 Standard Deviations Delay
A bone age that is 2 standard deviations below chronological age (bone age approximately 12.6 years in a 14.5-year-old) indicates significant skeletal maturation delay that warrants thorough evaluation for underlying endocrine disorders, chronic systemic disease, or constitutional growth delay.
Understanding the Result
- Standard deviation interpretation: In pediatric bone age assessment, Z-scores (standard deviations from age-matched norms) should be used rather than T-scores, as T-scores compare to adult peak bone mass and are inappropriate for children 1
- Clinical significance: A 2 SD delay represents approximately 1.9 years of skeletal maturation delay (14.5 - 12.6 = 1.9 years), which falls well outside the normal variation range 1
- Body size considerations: Bone mineral density and skeletal maturation can be significantly influenced by height and weight deviations from age-matched peers, with nearly 1 in 5 children showing differences of more than 1 unit when body size is not accounted for 2
Differential Diagnosis to Consider
Endocrine causes (most common):
- Growth hormone deficiency
- Hypothyroidism
- Hypogonadism or delayed puberty
- Cushing syndrome (chronic glucocorticoid exposure)
- 1
Chronic systemic diseases:
- Inflammatory bowel disease
- Celiac disease
- Chronic kidney disease
- Malnutrition or eating disorders
- 1
Constitutional delay:
- Familial pattern of late maturation
- Often associated with delayed puberty
- Diagnosis of exclusion
- 1
Required Clinical Evaluation
Essential history elements:
- Growth velocity over past 1-2 years (plot on growth chart)
- Pubertal development stage (Tanner staging)
- Family history of delayed growth/puberty
- Chronic illness symptoms
- Medication history (especially glucocorticoids)
- Nutritional assessment
- 1
Laboratory workup indicated:
- Complete blood count, ESR/CRP
- Comprehensive metabolic panel
- Thyroid function tests (TSH, free T4)
- IGF-1 and IGFBP-3 (growth hormone axis)
- Celiac screening (tissue transglutaminase)
- Gonadotropins (LH, FSH) and sex hormones
- Bone age films of left hand/wrist for confirmation
- 1
Management Approach
Immediate actions:
- Refer to pediatric endocrinology for comprehensive evaluation if not already done 1
- Document height velocity and plot on appropriate growth curves 2
- Assess for signs of underlying pathology requiring urgent intervention 1
Monitoring strategy:
- Repeat bone age assessment in 6-12 months to assess progression 1
- Serial height measurements every 3-6 months to calculate growth velocity 2
- Use same imaging facility and technique for accurate comparison, as measurement variability can be significant 3
Critical Pitfalls to Avoid
- Do not dismiss as "constitutional delay" without excluding pathologic causes through appropriate endocrine and systemic disease workup 1
- Avoid using T-scores in pediatric populations, as this leads to mislabeling children as "osteoporotic" when comparing to adult norms 1
- Account for body size deviations: Height and weight significantly influence bone density measurements, and failure to adjust can alter clinical management in nearly 20% of cases 2
- Recognize measurement limitations: Single measurements have inherent variability, and confidence intervals can be wide, particularly in those with low measured values 4
- Do not delay referral: A 2 SD delay represents clinically significant deviation requiring specialist evaluation, as delayed diagnosis of treatable conditions (hypothyroidism, growth hormone deficiency) can result in permanent height loss 1